These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37264173)

  • 21. Teaching Targeted Drug Discovery and Development to Healthcare Professionals.
    Fruchter R; Ahmad M; Pillinger M; Galeano C; Cronstein BN; Gold-von Simson G
    Clin Transl Sci; 2018 May; 11(3):277-282. PubMed ID: 29110398
    [No Abstract]   [Full Text] [Related]  

  • 22. A Perspective on Synthetic Biology in Drug Discovery and Development-Current Impact and Future Opportunities.
    David F; Davis AM; Gossing M; Hayes MA; Romero E; Scott LH; Wigglesworth MJ
    SLAS Discov; 2021 Jun; 26(5):581-603. PubMed ID: 33834873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How to rekindle drug discovery process through integrative therapeutic targeting?
    Vaidya A; Roy A; Chaguturu R
    Expert Opin Drug Discov; 2018 Oct; 13(10):893-898. PubMed ID: 30146919
    [No Abstract]   [Full Text] [Related]  

  • 24. ENABLE: an engine for European antibacterial drug discovery and development.
    Olliver M; Griestop L; Hughes D; Belfrage AK; Gising J; Baranczewski P; Vingsbo Lundberg C; Karlén A
    Nat Rev Drug Discov; 2021 Jun; 20(6):407-408. PubMed ID: 33948003
    [No Abstract]   [Full Text] [Related]  

  • 25. How can we better realize the potential of immobilized artificial membrane chromatography in drug discovery and development?
    Tsantili-Kakoulidou A
    Expert Opin Drug Discov; 2020 Mar; 15(3):273-276. PubMed ID: 32067506
    [No Abstract]   [Full Text] [Related]  

  • 26. Translational in vitro research: integrating 3D drug discovery and development processes into the drug development pipeline.
    Kelm JM; Lal-Nag M; Sittampalam GS; Ferrer M
    Drug Discov Today; 2019 Jan; 24(1):26-30. PubMed ID: 30071313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomaterials and Microfluidics for Drug Discovery and Development.
    Carvalho MR; Truckenmuller R; Reis RL; Oliveira JM
    Adv Exp Med Biol; 2020; 1230():121-135. PubMed ID: 32285368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is there enough focus on lipophilicity in drug discovery?
    Lobo S
    Expert Opin Drug Discov; 2020 Mar; 15(3):261-263. PubMed ID: 31736369
    [No Abstract]   [Full Text] [Related]  

  • 29. What are the economic barriers of antibiotic R&D and how can we overcome them?
    Renwick M; Mossialos E
    Expert Opin Drug Discov; 2018 Oct; 13(10):889-892. PubMed ID: 30175625
    [No Abstract]   [Full Text] [Related]  

  • 30. How to utilize academic research efforts in cancer drug discovery.
    Bérubé G
    Expert Opin Drug Discov; 2019 Apr; 14(4):331-334. PubMed ID: 30784328
    [No Abstract]   [Full Text] [Related]  

  • 31. AI-based language models powering drug discovery and development.
    Liu Z; Roberts RA; Lal-Nag M; Chen X; Huang R; Tong W
    Drug Discov Today; 2021 Nov; 26(11):2593-2607. PubMed ID: 34216835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Perspectives on Machine Learning in Drug Discovery.
    Musella S; Verna G; Fasano A; Di Micco S
    Curr Med Chem; 2021; 28(32):6704-6728. PubMed ID: 33176630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development.
    Takebe T; Imai R; Ono S
    Clin Transl Sci; 2018 Nov; 11(6):597-606. PubMed ID: 29940695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application and Impact of Human Dose Projection from Discovery to Early Drug Development.
    Patel D; Yang W; Lipert M; Wu T
    AAPS PharmSciTech; 2020 Jan; 21(2):44. PubMed ID: 31897807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzymes as Targets for Drug Development II.
    Kim SK
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steps to address anti-microbial drug resistance in today's drug discovery.
    Parish T
    Expert Opin Drug Discov; 2019 Feb; 14(2):91-94. PubMed ID: 30466326
    [No Abstract]   [Full Text] [Related]  

  • 37. Extracting molecular information from African natural products to facilitate unique African-led drug-discovery efforts.
    Chibale K; Guantai EM; Masimirembwa C
    Future Med Chem; 2011 Mar; 3(3):257-61. PubMed ID: 21446839
    [No Abstract]   [Full Text] [Related]  

  • 38. Trends in peptide drug discovery.
    Muttenthaler M; King GF; Adams DJ; Alewood PF
    Nat Rev Drug Discov; 2021 Apr; 20(4):309-325. PubMed ID: 33536635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data.
    Conrado DJ; Duvvuri S; Geerts H; Burton J; Biesdorf C; Ahamadi M; Macha S; Hather G; Francisco Morales J; Podichetty J; Nicholas T; Stephenson D; Trame M; Romero K; Corrigan B;
    Clin Pharmacol Ther; 2020 Apr; 107(4):796-805. PubMed ID: 31955409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Perspective on Quantitative Systems Pharmacology Applications to Clinical Drug Development.
    Bai JPF; Earp JC; Strauss DG; Zhu H
    CPT Pharmacometrics Syst Pharmacol; 2020 Dec; 9(12):675-677. PubMed ID: 33159491
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.